These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32115576)

  • 21. Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.
    Ishida CT; Zhang Y; Bianchetti E; Shu C; Nguyen TTT; Kleiner G; Sanchez-Quintero MJ; Quinzii CM; Westhoff MA; Karpel-Massler G; Prabhu VV; Allen JE; Siegelin MD
    Clin Cancer Res; 2018 Nov; 24(21):5392-5406. PubMed ID: 30037819
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.
    Prabhu VV; Madhukar NS; Gilvary C; Kline CLB; Oster S; El-Deiry WS; Elemento O; Doherty F; VanEngelenburg A; Durrant J; Tarapore RS; Deacon S; Charter N; Jung J; Park DM; Gilbert MR; Rusert J; Wechsler-Reya R; Arrillaga-Romany I; Batchelor TT; Wen PY; Oster W; Allen JE
    Clin Cancer Res; 2019 Apr; 25(7):2305-2313. PubMed ID: 30559168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Dopamine Receptors in the Anticancer Activity of ONC201.
    Kline CLB; Ralff MD; Lulla AR; Wagner JM; Abbosh PH; Dicker DT; Allen JE; El-Deiry WS
    Neoplasia; 2018 Jan; 20(1):80-91. PubMed ID: 29216597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.
    Landis CJ; Tran AN; Scott SE; Griguer C; Hjelmeland AB
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):175-188. PubMed ID: 29378228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R406 elicits anti-Warburg effect via Syk-dependent and -independent mechanisms to trigger apoptosis in glioma stem cells.
    Sun S; Xue D; Chen Z; Ou-Yang Y; Zhang J; Mai J; Gu J; Lu W; Liu X; Liu W; Sheng L; Lu B; Lin Y; Xing F; Chen Z; Mou Y; Yan G; Zhu W; Sai K
    Cell Death Dis; 2019 May; 10(5):358. PubMed ID: 31043589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.
    Prabhu VV; Talekar MK; Lulla AR; Kline CLB; Zhou L; Hall J; Van den Heuvel APJ; Dicker DT; Babar J; Grupp SA; Garnett MJ; McDermott U; Benes CH; Pu JJ; Claxton DF; Khan N; Oster W; Allen JE; El-Deiry WS
    Cell Cycle; 2018; 17(4):468-478. PubMed ID: 29157092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptive mitochondrial reprogramming and resistance to PI3K therapy.
    Ghosh JC; Siegelin MD; Vaira V; Faversani A; Tavecchio M; Chae YC; Lisanti S; Rampini P; Giroda M; Caino MC; Seo JH; Kossenkov AV; Michalek RD; Schultz DC; Bosari S; Languino LR; Altieri DC
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25650317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-MYC inhibition impairs hypoxia response in glioblastoma multiforme.
    Mongiardi MP; Savino M; Falchetti ML; Illi B; Bozzo F; Valle C; Helmer-Citterich M; Ferrè F; Nasi S; Levi A
    Oncotarget; 2016 May; 7(22):33257-71. PubMed ID: 27119353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells.
    Amoroso F; Glass K; Singh R; Liberal F; Steele RE; Maguire S; Tarapore R; Allen JE; Van Schaeybroeck S; Butterworth KT; Prise K; O'Sullivan JM; Jain S; Waugh DJ; Mills IG
    Sci Rep; 2021 Feb; 11(1):4252. PubMed ID: 33608585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.
    Du S; Sarver JG; Trabbic CJ; Erhardt PW; Schroering A; Maltese WA
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):237-254. PubMed ID: 30426158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
    Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the DRD2/3 antagonist ONC201 and radiation in glioblastoma.
    He L; Bhat K; Ioannidis A; Zhang L; Nguyen NT; Allen JE; Nghiemphu PL; Cloughesy TF; Liau LM; Kornblum HI; Pajonk F
    Radiother Oncol; 2021 Aug; 161():140-147. PubMed ID: 34097975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Energy Metabolism in
    van Noorden CJF; Hira VVV; van Dijck AJ; Novak M; Breznik B; Molenaar RJ
    Cells; 2021 Mar; 10(3):. PubMed ID: 33810170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of ONC201 and TLY012 induces selective, synergistic apoptosis in vitro and significantly delays PDAC xenograft growth in vivo.
    Jhaveri AV; Zhou L; Ralff MD; Lee YS; Navaraj A; Carneiro BA; Safran H; Prabhu VV; Ross EA; Lee S; El-Deiry WS
    Cancer Biol Ther; 2021 Dec; 22(10-12):607-618. PubMed ID: 34856854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
    Watanabe T; Ohtani T; Aihara M; Ishiuchi S
    J Neurosurg; 2013 Apr; 118(4):838-45. PubMed ID: 23311938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma.
    Li Z; Mbah NE; Overmeyer JH; Sarver JG; George S; Trabbic CJ; Erhardt PW; Maltese WA
    BMC Cancer; 2019 Jan; 19(1):77. PubMed ID: 30651087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration.
    Fròsina G; Profumo A; Marubbi D; Marcello D; Ravetti JL; Daga A
    Radiat Oncol; 2018 Apr; 13(1):76. PubMed ID: 29685176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
    Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
    Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells.
    Talekar MK; Allen JE; Dicker DT; El-Deiry WS
    Cell Cycle; 2015 Aug; 14(15):2422-8. PubMed ID: 26030065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.
    Agnihotri S; Zadeh G
    Neuro Oncol; 2016 Feb; 18(2):160-72. PubMed ID: 26180081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.